Zobrazeno 1 - 10
of 9 362
pro vyhledávání: '"early breast cancer"'
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract ER+/HER2- breast cancer is a common subtype of breast cancer. This study aimed to evaluate the prognostic value of ER-to-PR difference (EPD) in ER+/HER2- early breast cancer (EBC). A retrospective cohort study was conducted, including 3,340
Externí odkaz:
https://doaj.org/article/b16147e007f44f32951bcb67ae88a6e0
Autor:
Ali Hasan Abdulla, Reem Althawadi, Ahmed Zuhair Salman, Tareq Hamed Altaei, Amina Mohamed Mahdi, Hussain Adnan Abdulla
Publikováno v:
European Journal of Breast Health, Vol 20, Iss 4, Pp 270-276 (2024)
Objective: The Sentinel Node vs. Observation After Axillary Ultra-Sound (SOUND) trial reported that omission of axillary surgery was not inferior to sentinel lymph node biopsy (SLNB) in those with cT1 breast cancer and negative preoperative axillary
Externí odkaz:
https://doaj.org/article/72e33a26a1d54c60a902acfbe25c1383
Autor:
Jenna Dean, Nigel Anderson, Georgia K. B. Halkett, Jessica Lye, Mark Tacey, Farshad Foroudi, Michael Chao, Caroline Wright
Publikováno v:
Radiation Oncology, Vol 19, Iss 1, Pp 1-8 (2024)
Abstract Background Accelerated partial breast irradiation (APBI) is an accepted treatment option for early breast cancer. Treatment delivered on the Magnetic Resonance integrated Linear Accelerator (MRL) provides the added assurance of improved soft
Externí odkaz:
https://doaj.org/article/14887af25877477983b15caa0fb588e7
Autor:
Jiahui Ren, Yili Li, Jing Zhou, Ting Yang, Jingfeng Jing, Qian Xiao, Zhongxu Duan, Ke Xiang, Yuchen Zhuang, Daxue Li, Han Gao
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract This study aimed to compare the long-term outcomes of breast-conserving surgery plus radiotherapy (BCS + RT) and mastectomy in early breast cancer (EBC) patients who received neoadjuvant systemic therapy (NST), and sought to construct and au
Externí odkaz:
https://doaj.org/article/d09592c6be404a48837987e563c07ac2
Publikováno v:
Breast Cancer: Targets and Therapy, Vol Volume 16, Pp 517-527 (2024)
Kaitlyn O’Keefe, Neelam V Desai, Antoinette R Tan Department of Solid Tumor and Investigational Therapeutics, Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC, USACorrespondence: Antoinette R Tan, Depa
Externí odkaz:
https://doaj.org/article/be056c6ba056409ea620b5f2995cf652
New Insight for Axillary De-Escalation in Breast Cancer Surgery: 'SoFT Study' Retrospective Analysis
Autor:
Gianluca Vanni, Marco Materazzo, Floriana Paduano, Marco Pellicciaro, Giordana Di Mauro, Enrica Toscano, Federico Tacconi, Benedetto Longo, Valerio Cervelli, Massimiliano Berretta, Oreste Claudio Buonomo
Publikováno v:
Current Oncology, Vol 31, Iss 8, Pp 4141-4157 (2024)
Background: The SOUND study demonstrated that an axillary de-escalation may be sufficient in locoregional and distant disease control in selected early breast cancer (EBC) patients. To establish any preoperative variables that may drive sentinel lymp
Externí odkaz:
https://doaj.org/article/182c46d9fb4f45af934cec4b5438d36f
Autor:
Marcus Schmidt, Sibylle Loibl
Publikováno v:
Breast, Vol 78, Iss , Pp 103821- (2024)
The incidence of breast cancer increases with age. Particularly in ageing societies, breast cancer has a significant impact on both the older patient and the healthcare system. In older patients with early breast cancer, there is a complex interplay
Externí odkaz:
https://doaj.org/article/0cd7f65af05146c8ac2a3adde5a2ccbb
Publikováno v:
Cancer Biology & Therapy, Vol 25, Iss 1 (2024)
Hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2−) breast cancer is the most common subtype, representing over two-thirds of new diagnoses. Adjuvant therapy, which encompasses various medications and treatment
Externí odkaz:
https://doaj.org/article/32cdd99ecadd4fe3a5de98c79a4502cb
Autor:
Shuqin Dai, Xingping Wu, Xuefang Huang, Jibin Li, Xi Wang, Shusen Wang, Jun Tang, Yanxia Shi, Xiaoming Xie, Fei Xu, Peng Liu, Jiajia Huang, Xinhua Xie, Xin An, Meiting Chen, Rouxi Hong, Wen Xia, Qiufan Zheng, Kuikui Jiang, Yongyi Zhong, Zhongyu Yuan, Yuanyuan Huang, Xiwen Bi, Cong Xue
Publikováno v:
Breast, Vol 78, Iss , Pp 103818- (2024)
Purpose: The limited understanding of long-term estradiol (E2) suppression poses challenges to the effectiveness of adjuvant therapy with aromatase inhibitors (AI), necessitating comprehensive serum E2 monitoring to address this issue. Therefore, our
Externí odkaz:
https://doaj.org/article/46a086553e6446878d66b4e1aac2b5cc
Autor:
Leonor Vasconcelos de Matos, Marcio Debiasi, Teresa Gantes Padrão, Berta Sousa, Fatima Cardoso
Publikováno v:
Breast, Vol 78, Iss , Pp 103793- (2024)
Introduction: The KEYNOTE-522 (KN-522) trial showed that the addition of pembrolizumab to standard chemotherapy improved pathological complete response (pCR) and event-free survival (EFS) for patients with early triple negative breast cancer (TNBC).
Externí odkaz:
https://doaj.org/article/32ee534a75034f2cb821b54b813de3d6